1. Home
  2. IRD vs PODC Comparison

IRD vs PODC Comparison

Compare IRD & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • PODC
  • Stock Information
  • Founded
  • IRD 2018
  • PODC 2013
  • Country
  • IRD United States
  • PODC United States
  • Employees
  • IRD N/A
  • PODC N/A
  • Industry
  • IRD
  • PODC
  • Sector
  • IRD
  • PODC
  • Exchange
  • IRD NYSE
  • PODC Nasdaq
  • Market Cap
  • IRD 36.0M
  • PODC 29.7M
  • IPO Year
  • IRD N/A
  • PODC N/A
  • Fundamental
  • Price
  • IRD $1.13
  • PODC $1.97
  • Analyst Decision
  • IRD Strong Buy
  • PODC Strong Buy
  • Analyst Count
  • IRD 1
  • PODC 2
  • Target Price
  • IRD $8.00
  • PODC $4.75
  • AVG Volume (30 Days)
  • IRD 150.5K
  • PODC 33.0K
  • Earning Date
  • IRD 02-24-2025
  • PODC 02-12-2025
  • Dividend Yield
  • IRD N/A
  • PODC N/A
  • EPS Growth
  • IRD N/A
  • PODC N/A
  • EPS
  • IRD N/A
  • PODC N/A
  • Revenue
  • IRD $8,381,000.00
  • PODC $49,729,000.00
  • Revenue This Year
  • IRD N/A
  • PODC $20.42
  • Revenue Next Year
  • IRD $29.37
  • PODC $19.38
  • P/E Ratio
  • IRD N/A
  • PODC N/A
  • Revenue Growth
  • IRD N/A
  • PODC 22.98
  • 52 Week Low
  • IRD $0.81
  • PODC $1.10
  • 52 Week High
  • IRD $2.71
  • PODC $2.85
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • PODC 38.08
  • Support Level
  • IRD N/A
  • PODC $1.88
  • Resistance Level
  • IRD N/A
  • PODC $2.30
  • Average True Range (ATR)
  • IRD 0.00
  • PODC 0.23
  • MACD
  • IRD 0.00
  • PODC -0.04
  • Stochastic Oscillator
  • IRD 0.00
  • PODC 24.29

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: